MedTrace Logo

The Angioshield Study Feasibility II

NCT02543047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2018-05-25

No results posted yet for this study

Summary

Feasibility Study to Demonstrate the Safety of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery.

Conditions

Interventions

DEVICE

Angioshield

Angioshield is applied to vein graft to provide Mechanical Support for Vein Grafts Used in CABG Surgery

Sponsors & Collaborators

  • Neograft Technologies, Incorporated

    lead INDUSTRY

Principal Investigators

  • Gintaras Kalinauskas, MD · Santariskiu University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-03-31
Completion
2018-03-07

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02543047 on ClinicalTrials.gov